Your browser doesn't support javascript.
loading
A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.
Gould, Rebecca L; Thompson, Benjamin J; Rawlinson, Charlotte; Kumar, Pavithra; White, David; Serfaty, Marc A; Graham, Christopher D; McCracken, Lance M; Bursnall, Matt; Bradburn, Mike; Young, Tracey; Howard, Robert J; Al-Chalabi, Ammar; Goldstein, Laura H; Lawrence, Vanessa; Cooper, Cindy; Shaw, Pamela J; McDermott, Christopher J.
Affiliation
  • Gould RL; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK. r.gould@ucl.ac.uk.
  • Thompson BJ; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Rawlinson C; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK.
  • Kumar P; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • White D; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Serfaty MA; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK.
  • Graham CD; Priory Hospital North London, London, UK.
  • McCracken LM; School of Psychology, Queen's University Belfast, Belfast, Northern Ireland.
  • Bursnall M; Department of Psychology, Uppsala University, Uppsala, Sweden.
  • Bradburn M; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Young T; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Howard RJ; School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Al-Chalabi A; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK.
  • Goldstein LH; Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
  • Lawrence V; Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Cooper C; Health Services & Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Shaw PJ; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • McDermott CJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
BMC Neurol ; 22(1): 431, 2022 Nov 15.
Article in En | MEDLINE | ID: mdl-36380299
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Motor Neuron Disease / Neurodegenerative Diseases / Acceptance and Commitment Therapy Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Humans Language: En Journal: BMC Neurol Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Motor Neuron Disease / Neurodegenerative Diseases / Acceptance and Commitment Therapy Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Humans Language: En Journal: BMC Neurol Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: